Plate Nº 56 · recorded October 10, 2026
Health & Medicine ResearchReported finding
Most Young Colorectal Cancer Patients Are Diagnosed Late, Study Finds
A study of 84 patients aged 21 or younger found most had Stage III-IV colorectal cancer at diagnosis, and nearly half died. Researchers urge vigilance.
By Nathan Brooks3 min read559 words
In brief
- 84 patients aged 21 or younger diagnosed with colorectal cancer between 2012 and 2023 were reviewed.
- Most patients already had Stage III or IV disease at diagnosis.
- Only 20% had a family history of colorectal cancer in first- or second-degree relatives.
- Nearly half of the patients died; more than one-third developed recurrent disease.
- Findings were presented October 2-6, 2026, at the AAP National Conference in San Diego.
Nearly half of colorectal cancer patients aged 21 or younger died after their diagnosis, according to a new study that reviewed 84 medical records from 2012 to 2023. Most of these young patients already had Stage III or Stage IV disease — advanced cancer that had spread beyond the colon — by the time doctors found it.
Researchers presented the findings at the American Academy of Pediatrics 2026 National Conference & Exhibition, held October 2–6 at the San Diego Convention Center. The study, conducted through the Pediatric Surgical Oncology Research Collaborative, adds to mounting evidence that a cancer long associated with older adults is appearing more often in adolescents and young adults, and being caught too late.
Only 20% of the patients had a first- or second-degree relative with colorectal cancer, meaning family history alone cannot explain who is at risk. Despite that lack of inherited risk, most patients had aggressive disease that had already reached an advanced stage at diagnosis.
What symptoms should young people watch for?
The researchers urge patients and clinicians to take the following warning signs seriously:
- Rectal bleeding
- Unexplained weight loss
- Abdominal pain
- Changes in bowel habits
- Lower back pain
Because colorectal cancer remains uncommon in younger patients, these symptoms may not immediately raise suspicion. Doctors may attribute them to more common, benign causes, and diagnosis can be delayed. That delay, combined with the aggressive behavior of tumors in this age group, can contribute to poor long-term outcomes, the authors write.
The study suggests this is not simply a younger version of the same disease. "Colorectal cancer is, unfortunately, becoming more common in adolescents and young adults and represents a different disease than colorectal cancer diagnosed in older adults," said study author Erica Arnold, MD, a pediatric surgery research fellow.
How severe were the outcomes?
The numbers from the 84-patient cohort paint a sobering picture. More than one-third of the patients later developed recurrent disease — the cancer came back after treatment. Nearly half died as a result of their diagnosis.
"When diagnosed, it is often aggressive, presenting with late-stage disease and associated with high rates of disease relapse and mortality," Arnold said.
The researchers say symptoms such as unexplained weight loss and rectal bleeding should never be dismissed in younger patients simply because of their age.
What should change in care?
As cancers typically associated with adults continue to appear at younger ages, the authors stress two priorities:
- Coordinating care between pediatric and adult medical teams, so young patients benefit from expertise on both sides
- Developing treatment plans specifically tailored to this age group, rather than borrowing approaches designed for older adults
The study has limitations worth keeping in mind. It is a retrospective review of 84 patients — a small sample for a rare disease — and findings presented at a conference may not yet have undergone full peer review. The results still signal a clear trend, but they are preliminary in the sense that larger studies will be needed to confirm patterns of incidence and outcomes.
Even with those caveats, the message for families and clinicians is direct: rectal bleeding and unexplained weight loss in a teenager or young adult deserve a serious medical workup, not a wait-and-see approach. Early recognition remains the strongest tool available against a disease that, in this young population, too often announces itself late.
via ScienceDaily: Health & Medicine (Source)
More from Nathan Brooks
Nearby plates
- Age-Based Cancer Genetic Testing Misses 72% of Inherited Variants
- Mayo Clinic Study Maps Gut Microbes Across 1,364 Cancer Patients
- Mayo Clinic Highlights Two Advances in Pancreatic Cancer
- One in Eight Cancers Worldwide Likely Linked to Infections
- Some Healthy Organs Carry Cancer-Level Mutation Counts, Study Finds